BiotechTube

CellCept (mycophenolate mofetil)

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

MPO-ANCA Vasculitis

Conditions

MPO-ANCA Vasculitis, Microscopic Polyangiitis

Trial Timeline

Dec 1, 2002 → Jul 1, 2008

NCT ID
NCT00405860

About CellCept (mycophenolate mofetil)

CellCept (mycophenolate mofetil) is a phase 1 stage product being developed by Roche for MPO-ANCA Vasculitis. The current trial status is completed. This product is registered under clinical trial identifier NCT00405860. Target conditions include MPO-ANCA Vasculitis, Microscopic Polyangiitis.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT00281619Pre-clinicalCompleted
NCT00405860Phase 1Completed

Other Products from Roche

EmicizumabApproved
85
rituximab + methotrexate + methylprednisolone + acetaminophen + antihistamineApproved
85
RituximabApproved
85
mycophenolate mofetil [CellCept]Approved
85
saquinavir/ritonavir + atazanavir/ritonavirApproved
85